Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 18, 2011, Pages 7523-7528

  Schwaeble, Wilhelm J ^a   Lynch, Nicholas J ^a   Clark, James E ^b   Marber, Michael ^b   Samani, Nilesh J ^a   Ali, Youssif Mohammed ^a,c   Dudler, Thomas ^d   Parent, Brian ^d   Lhotta, Karl ^e   Wallis, Russell ^a   Farrar, Conrad A ^f   Sacks, Steven ^f   Lee, Haekyung ^g   Zhang, Ming ^g   Iwaki, Daisuke ^h   Takahashi, Minoru ^h   Fujita, Teizo ^h   Tedford, Clark E ^d   Stover, Cordula M ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c MANSOURA UNIVERSITY   (Egypt)

^d OMEROS CORPORATION   (United States)

^e Landeskrankenhaus Feldkirch   (Austria)

^f GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^g SUNY Downstate Medical Center   (United States)

^h FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C4; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 1; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 2; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 3; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE INJURY; INFLAMMATION; INTESTINE ISCHEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

ANIMALS; ANTIBODIES, MONOCLONAL; COMPLEMENT C4; FEMALE; GASTROINTESTINAL TRACT; MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MICROSCOPY; MYOCARDIUM; REPERFUSION INJURY;

MUS;

EID: 79956313936     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1101748108     Document Type: Article

References (49)

1. Weisman HF, et al. (1990) Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249:146-151.
2. Shandelya SM, Kuppusamy P, Weisfeldt ML, Zweier JL (1993) Evaluation of the role of polymorphonuclear leukocytes on contractile function in myocardial reperfusion injury. Evidence for plasma-mediated leukocyte activation. Circulation 87:536-546. (Pubitemid 23040923)
3. Collard CD, et al. (2000) Complement activation after oxidative stress: Role of the lectin complement pathway. Am J Pathol 156:1549-1556. (Pubitemid 30646694)
4. Walport MJ (2001) Complement. First of two parts. N Engl J Med 344:1058-1066.
5. Schwaeble W, Dahl MR, Thiel S, Stover C, Jensenius JC (2002) The mannan-binding lectin-associated serine proteases (MASPs) and MAp19: Four components of the lectin pathway activation complex encoded by two genes. Immunobiology 205:455-466. (Pubitemid 35153961)
6. Fujita T (2002) Evolution of the lectin-complement pathway and its role in innate immunity. Nat Rev Immunol 2:346-353.
7. Hansen S, et al. (2010) Collectin 11 (CL-11, CL-K1) is a MASP-1/3-associated plasma collectin with microbial-binding activity. J Immunol 185:6096-6104.
8. Thiel S, et al. (1997) A second serine protease associated with mannan-binding lectin that activates complement. Nature 386:506-510. (Pubitemid 27164078)
9. Stover CM, et al. (1999) Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. J Immunol 162:3481-3490. (Pubitemid 29313599)
10. Takahashi M, Endo Y, Fujita T, Matsushita M (1999) A truncated form of mannose-binding lectin-associated serine protease (MASP)-2 expressed by alternative polyadenylation is a component of the lectin complement pathway. Int Immunol 11:859-863. (Pubitemid 29237776)
11. Stover CM, Thiel S, Lynch NJ, Schwaeble WJ (1999) The rat and mouse homologues of MASP-2 and MAp19, components of the lectin activation pathway of complement. J Immunol 163:6848-6859.
12. Iwaki D, et al. (2006) Small mannose-binding lectin-associated protein plays a regulatory role in the lectin complement pathway. J Immunol 177:8626-8632. (Pubitemid 44893826)
13. Vorup-Jensen T, et al. (2000) Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2. J Immunol 165:2093-2100. (Pubitemid 30643158)
14. Thiel S, et al. (2000) Interaction of C1q and mannan-binding lectin (MBL) with C1r, C1s, MBL-associated serine proteases 1 and 2, and the MBL-associated protein MAp19. J Immunol 165:878-887. (Pubitemid 30484755)
15. Rossi V, et al. (2001) Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and -2. J Biol Chem 276:40880-40887.
16. Takahashi M, et al. (2008) Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway. J Immunol 180:6132-6138.
17. Takahashi M, et al. (2010) Essential role of mannose-binding lectin-associated serine protease-1 in activation of the complement factor D. J Exp Med 207:29-37.
18. Takahashi K, et al. (2002) Lack of mannose-binding lectin-A enhances survival in a mouse model of acute septic peritonitis. Microbes Infect 4:773-784. (Pubitemid 35247440)
19. Tanno M, et al. (2003) Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: Evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia. Circ Res 93:254-261. (Pubitemid 36993237)
20. May JE, Frank MM (1973) Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. I. Antibody and serum requirements. J Immunol 111:1671-1677.
21. Yang Y, et al. (2004) Complete complement components C4A and C4B deficiencies in human kidney diseases and systemic lupus erythematosus. J Immunol 173:2803-2814. (Pubitemid 39063142)
22. Zhang M, et al. (2004) Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc Natl Acad Sci USA 101:3886-3891. (Pubitemid 38381072)
23. Zhang M, et al. (2006) Identification of the target self-antigens in reperfusion injury. J Exp Med 203:141-152. (Pubitemid 43139653)
24. Hart ML, et al. (2005) Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q. J Immunol 174:6373-6380. (Pubitemid 40663830)
25. Walsh MC, et al. (2005) Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury. J Immunol 175:541-546. (Pubitemid 40884360)
26. Zhang M, et al. (2006) Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury. J Immunol 177:4727-4734. (Pubitemid 44469806)
27. McMullen ME, et al. (2006) Mannose-binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo. Immunobiology 211:759-766. (Pubitemid 44767225)
28. Møller-Kristensen M, et al. (2005) Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury. Scand J Immunol 61:426-434. (Pubitemid 40695013)
29. Norwood MG, et al. (2006) Consumption of mannan-binding lectin during abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 31:239-243. (Pubitemid 43263503)
30. Thurman JM, Ljubanovic D, Edelstein CL, Gilkeson GS, Holers VM (2003) Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J Immunol 170:1517-1523. (Pubitemid 36139523)
31. Gulla KC, et al. (2010) Activation of mannan-binding lectin-associated serine proteases leads to generation of a fibrin clot. Immunology 129:482-495.
32. Schweinle JE, Ezekowitz RA, Tenner AJ, Kuhlman M, Joiner KA (1989) Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose-rich isolate of Salmonella. J Clin Invest 84:1821-1829. (Pubitemid 20016186)
33. Selander B, et al. (2006) Mannan-binding lectin activates C3 and the alternative complement pathway without involvement of C2. J Clin Invest 116:1425-1434.
34. Atkinson JP, Frank MM (2006) Bypassing complement: Evolutionary lessons and future implications. J Clin Invest 116:1215-1218.
35. Clark A, et al. (2008) Evidence for non-traditional activation of complement factor C3 during murine liver regeneration. Mol Immunol 45:3125-3132.
36. Møller-Kristensen M, Thiel S, Sjöholm A, Matsushita M, Jensenius JC (2007) Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway. Int Immunol 19:141-149. (Pubitemid 46179009)
37. Brown JS, et al. (2002) The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci USA 99:16969-16974. (Pubitemid 36034082)
38. Boos LA, Szalai AJ, Barnum SR (2005) Murine complement C4 is not required for experimental autoimmune encephalomyelitis. Glia 49:158-160. (Pubitemid 40023662)
39. Lin T, et al. (2006) Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. Am J Pathol 168:1241-1248.
40. Farrar CA, et al. (2009) Mannan binding lectin associated serine protease-2 (MASP-2) is a critical player in the pathophysiology of renal ischaemia reperfusion (I/R) injury and mediates tissue injury in absence of complement C4. Mol Immunol 46:2832.
41. Møller-Kristensen M, et al. (2003) Levels of mannan-binding lectin-associated serine protease-2 in healthy individuals. J Immunol Methods 282:159-167. (Pubitemid 37357041)
42. Iwaki D, Fujita T (2005) Production and purification of recombinants of mouse MASP-2 and sMAP. J Endotoxin Res 11:47-50. (Pubitemid 40533079)
43. Chen CB, Wallis R (2004) Two mechanisms for mannose-binding protein modulation of the activity of its associated serine proteases. J Biol Chem 279:26058-26065.
44. Knappik A, et al. (2000) Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J Mol Biol 296:57-86.
45. Lynch NJ, et al. (2004) L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement. J Immunol 172:1198-1202. (Pubitemid 38113782)
46. Fischer MB, et al. (1996) Regulation of the B cell response to T-dependent antigens by classical pathway complement. J Immunol 157:549-556.
47. Eckle T, et al. (2006) Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am J Physiol Heart Circ Physiol 291:H2533-H2540.
48. Clark JE, Kottam A, Motterlini R, Marber MS (2009) Measuring left ventricular function in the normal, infarcted and CORM-3-preconditioned mouse heart using complex admittance-derived pressure volume loops. J Pharmacol Toxicol Methods 59:94-99.
49. Sicard P, et al. (2010) The activation of p38 alpha, and not p38 beta, mitogen-activated protein kinase is required for ischemic preconditioning. J Mol Cell Cardiol 48:1324-1328.